Cash & equivalents increased 33.1%
Cash & equivalents changed +33.1% from the comparable as-filed period.
$372.0M→$495.3M2 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +33.1% from the comparable as-filed period.
Inventory changed +20.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed +28.2% from the comparable as-filed period.
Inventory / revenue changed +1268 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.